Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007
(Ciclosporin 0.1%) Ophthalmic Cationic Emulsion versus Vehicle in Patients with Moderate to
Severe Dry Eye Syndrome